Pear Therapeutics Inc Revenue Growth Rates (PEAR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pear Therapeutics Inc   (NASDAQ: PEAR)
 

PEAR's Revenue Growth by Quarter and Year

Pear Therapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PEAR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December 2.57
3rd Quarter September 4.08
2nd Quarter June 3.30
1st Quarter March 2.75
FY 12.70





PEAR Revenue fourth quarter 2022 Y/Y Growth Comment
Pear Therapeutics Inc achieved in the fourth quarter 2022, above Company average Revenue rise of 94.32% year on year, to $ 2.57 millions.

Looking into fourth quarter 2022 results within Medical Equipment & Supplies industry 162 other companies have achieved higher Revenue growth. While Pear Therapeutics Inc ' s Revenue jump of 94.32% ranks overall at the positon no. 3792 in the fourth quarter 2022.


PEAR Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December 94.32 % - - -
3rd Quarter September 211.45 % - - -
2nd Quarter June 175 % - - -
1st Quarter March 623.68 % - - -
FY   201.54 % - - -

Financial Statements
Pear Therapeutics Inc 's fourth quarter 2022 Revenue $ 2.57 millions PEAR's Income Statement
Pear Therapeutics Inc 's fourth quarter 2021 Revenue $ 1.32 millions Quarterly PEAR's Income Statement


PEAR Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December -37.13 % 0.76 % - -
3rd Quarter September 23.64 % 9.17 % - -
2nd Quarter June 20 % 215.79 % - -
1st Quarter March 108.33 % - - -
FY (Year on Year)   201.54 % - - -


Back to PEAR Growth rate Comparisons >> Back to PEAR Growth rate Comparisons >>


Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #163
Healthcare Sector #556
Overall #3792

Revenue Y/Y Growth Statistics
High Average Low
-39.04 % -39.04 % -39.04 %
(Dec 31 2022)  
Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #163
Healthcare Sector #556
Overall #3792
Revenue Y/Y Growth Statistics
High Average Low
-39.04 % -39.04 % -39.04 %
(Dec 31 2022)  

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pear Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
23.84 % -7.02 % -37.18 %
(Sep 30 2022)  


PEAR's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2022 Pear Therapeutics Inc disclosed fall in Revenue from the third quarter by -37.13% to $ 2.57 millions, from $ 4.08 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2022 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 196 other companies have achieved higher Revenue quarter on quarter growth. While Pear Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 4126.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #197
Healthcare Sector #656
Overall #4126
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #197
Healthcare Sector #656
Overall #4126
Revenue Q/Q Growth Statistics
High Average Low
23.84 % -7.02 % -37.18 %
(Sep 30 2022)  


PEAR's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2022 Pear Therapeutics Inc disclosed fall in Revenue from the third quarter by -37.13% to $ 2.57 millions, from $ 4.08 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2022 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 196 other companies have achieved higher Revenue quarter on quarter growth. While Pear Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 4126.


Pear Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 12.69 $ 14.34 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 201.66 % - - - -
Year on Year Revenue Growth Overall Ranking # 183 # 183 # 183 # 183 # 183
Seqeuential Revenue Change (TTM) 10.87 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3502 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 201.66% annual Revenue growth, Pear Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Dec 31 2022.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 183.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 47
Overall # 177

Revenue TTM Y/Y Growth Statistics
High Average Low
201.66 %
 201.66 %
201.66 %
(Dec 31 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 474
S&P 500 # 3502
Cumulative Revenue growth Comment
With 201.66% annual Revenue growth, Pear Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Dec 31 2022.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 183.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 47
Overall # 177

Revenue TTM Y/Y Growth Statistics
High Average Low
201.66 %
201.66 %
201.66 %
(Dec 31 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 474
S&P 500 # 3502




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PEAR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Agile Therapeutics Inc164.04%$ 164.045 millions
Fate Therapeutics Inc 159.89%$ 159.893 millions
Scynexis Inc 155.28%$ 155.276 millions
Rigel Pharmaceuticals Inc151.25%$ 151.252 millions
Sera Prognostics Inc 150.00%$ 150.000 millions
Babylon Holdings Limited145.73%$ 145.729 millions
Luna Innovations Inc144.83%$ 144.833 millions
Repare Therapeutics Inc 144.82%$ 144.816 millions
Paratek Pharmaceuticals Inc 137.63%$ 137.631 millions
Dyadic International Inc 137.39%$ 137.392 millions
Procept Biorobotics Corporation134.53%$ 134.533 millions
Igc Pharma Inc 133.80%$ 133.803 millions
Innate Pharma Sa133.47%$ 133.470 millions
Lumos Pharma Inc 132.73%$ 132.727 millions
Collegium Pharmaceutical Inc 131.23%$ 131.229 millions
Arrowhead Pharmaceuticals Inc 127.95%$ 127.946 millions
Evoke Pharma Inc 120.86%$ 120.864 millions
Sanara Medtech Inc 117.76%$ 117.765 millions
Effector Therapeutics Inc 117.04%$ 117.042 millions
Rayont Inc 110.48%$ 110.484 millions
Kyntra Bio Inc 107.74%$ 107.737 millions
Lantheus Holdings Inc 103.12%$ 103.120 millions
Hookipa Pharma inc 100.98%$ 100.976 millions
Intelligent Bio Solutions Inc 100.62%$ 100.617 millions
Lexicon Pharmaceuticals Inc 100.00%$ 100.000 millions
Orgenesis Inc 97.68%$ 97.678 millions
Hims and Hers Health Inc 97.41%$ 97.408 millions
Emmaus Life Sciences Inc 96.36%$ 96.358 millions
Cvrx inc 96.17%$ 96.173 millions
Arbutus Biopharma Corp94.79%$ 94.791 millions


About Pear Therapeutics Inc Revenue Growth Rates (PEAR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pear Therapeutics Inc (CIK 1835567).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001835567-23-000018
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pear Therapeutics Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.